Advances in the diagnosis and management of neurocysticercosis

Jose A. Serpa, Linda S. Yancey, A. Clinton White

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Neurocysticercosis is the most common cause of late-onset epilepsy in developing countries. The larval stage of Taenia solium is the causative agent of the disease. Recent advances in neuroimaging and serologic diagnostic techniques have led to increased recognition of its importance, but its pathogenesis is just beginning to be clarified. Experts now agree that the clinical manifestations, pathogenic mechanisms and optimal treatment vary with the number of parasites, their location and the degree of host inflammation. Symptomatic therapy (i.e., antiepileptic medications and, when indicated, surgery) is critically important but there are also important roles for antiparasitic and antiinflammatory drugs. Neurocysticercosis is a potentially eradicable disease but this is probably unlikely to be achieved in the short term.

Original languageEnglish (US)
Pages (from-to)1051-1061
Number of pages11
JournalExpert Review of Anti-Infective Therapy
Volume4
Issue number6
DOIs
StatePublished - Dec 2006

Fingerprint

Neurocysticercosis
Taenia solium
Antiparasitic Agents
Neuroimaging
Anticonvulsants
Developing Countries
Epilepsy
Parasites
Anti-Inflammatory Agents
Inflammation
Therapeutics

Keywords

  • Albendazole
  • Cysticercosis
  • Hydrocephalus
  • Neurocysticercosis
  • Seizure
  • Taenia

ASJC Scopus subject areas

  • Infectious Diseases
  • Parasitology

Cite this

Advances in the diagnosis and management of neurocysticercosis. / Serpa, Jose A.; Yancey, Linda S.; White, A. Clinton.

In: Expert Review of Anti-Infective Therapy, Vol. 4, No. 6, 12.2006, p. 1051-1061.

Research output: Contribution to journalArticle

Serpa, Jose A. ; Yancey, Linda S. ; White, A. Clinton. / Advances in the diagnosis and management of neurocysticercosis. In: Expert Review of Anti-Infective Therapy. 2006 ; Vol. 4, No. 6. pp. 1051-1061.
@article{16ebffa406894529b42efcfe3ce05f96,
title = "Advances in the diagnosis and management of neurocysticercosis",
abstract = "Neurocysticercosis is the most common cause of late-onset epilepsy in developing countries. The larval stage of Taenia solium is the causative agent of the disease. Recent advances in neuroimaging and serologic diagnostic techniques have led to increased recognition of its importance, but its pathogenesis is just beginning to be clarified. Experts now agree that the clinical manifestations, pathogenic mechanisms and optimal treatment vary with the number of parasites, their location and the degree of host inflammation. Symptomatic therapy (i.e., antiepileptic medications and, when indicated, surgery) is critically important but there are also important roles for antiparasitic and antiinflammatory drugs. Neurocysticercosis is a potentially eradicable disease but this is probably unlikely to be achieved in the short term.",
keywords = "Albendazole, Cysticercosis, Hydrocephalus, Neurocysticercosis, Seizure, Taenia",
author = "Serpa, {Jose A.} and Yancey, {Linda S.} and White, {A. Clinton}",
year = "2006",
month = "12",
doi = "10.1586/14787210.4.6.1051",
language = "English (US)",
volume = "4",
pages = "1051--1061",
journal = "Expert Review of Anti-Infective Therapy",
issn = "1478-7210",
publisher = "Expert Reviews Ltd.",
number = "6",

}

TY - JOUR

T1 - Advances in the diagnosis and management of neurocysticercosis

AU - Serpa, Jose A.

AU - Yancey, Linda S.

AU - White, A. Clinton

PY - 2006/12

Y1 - 2006/12

N2 - Neurocysticercosis is the most common cause of late-onset epilepsy in developing countries. The larval stage of Taenia solium is the causative agent of the disease. Recent advances in neuroimaging and serologic diagnostic techniques have led to increased recognition of its importance, but its pathogenesis is just beginning to be clarified. Experts now agree that the clinical manifestations, pathogenic mechanisms and optimal treatment vary with the number of parasites, their location and the degree of host inflammation. Symptomatic therapy (i.e., antiepileptic medications and, when indicated, surgery) is critically important but there are also important roles for antiparasitic and antiinflammatory drugs. Neurocysticercosis is a potentially eradicable disease but this is probably unlikely to be achieved in the short term.

AB - Neurocysticercosis is the most common cause of late-onset epilepsy in developing countries. The larval stage of Taenia solium is the causative agent of the disease. Recent advances in neuroimaging and serologic diagnostic techniques have led to increased recognition of its importance, but its pathogenesis is just beginning to be clarified. Experts now agree that the clinical manifestations, pathogenic mechanisms and optimal treatment vary with the number of parasites, their location and the degree of host inflammation. Symptomatic therapy (i.e., antiepileptic medications and, when indicated, surgery) is critically important but there are also important roles for antiparasitic and antiinflammatory drugs. Neurocysticercosis is a potentially eradicable disease but this is probably unlikely to be achieved in the short term.

KW - Albendazole

KW - Cysticercosis

KW - Hydrocephalus

KW - Neurocysticercosis

KW - Seizure

KW - Taenia

UR - http://www.scopus.com/inward/record.url?scp=33845970223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845970223&partnerID=8YFLogxK

U2 - 10.1586/14787210.4.6.1051

DO - 10.1586/14787210.4.6.1051

M3 - Article

C2 - 17181420

AN - SCOPUS:33845970223

VL - 4

SP - 1051

EP - 1061

JO - Expert Review of Anti-Infective Therapy

JF - Expert Review of Anti-Infective Therapy

SN - 1478-7210

IS - 6

ER -